Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience

被引：0
|
作者：
Nayci, Sibel [1 ]
Polat, Demet [1 ]
Ozgur, Eylem Sercan [1 ]
Ozge, Cengiz [1 ]
机构：
[1] Mersin Univ, Mersin, Turkey
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Idiopathic pulmonary fibrosis; Spirometry; Treatments;
D O I：
10.1183/13993003.congress-2020.1845
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1845
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antifibrotic Persistence in Idiopathic Pulmonary Fibrosis: A Real-World Experience of 447 Patients
    Thillai, M.
    Harris, E.
    Harding, K.
    Babu, A.
    Verghese, P.
    Fiddler, C.
    Simler, N.
    Parfrey, H.
    Shah, R.
    McLellan, T.
    Atkins, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
    Qiu, Ying
    Zhu, Julia
    Elpers, Brandon
    Jiang, Jenny
    Ogbomo, Adesuwa
    Mallampati, Rajesh
    Byrne, Clare
    Tang, Jackson
    Fischer, Aryeh
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
    Cottin, Vincent
    Maher, Toby
    [J]. EUROPEAN RESPIRATORY REVIEW, 2015, 24 (135): : 58 - 64
  • [4] Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience
    Isshiki, Takuma
    Sakamoto, Susumu
    Yamasaki, Akira
    Shimizu, Hiroshige
    Miyoshi, Shion
    Nakamura, Yasuhiko
    Homma, Sakae
    Kishi, Kazuma
    [J]. RESPIRATORY MEDICINE, 2021, 187
  • [5] Long-Term Treatment with Nintedanib for Idiopathic Pulmonary Fibrosis in a Real-World Setting
    Kato, M.
    Sasaki, S.
    Arai, Y.
    Motomura, H.
    Sumiyoshi, I.
    Ochi, Y.
    Watanabe, J.
    Ihara, H.
    Togo, S.
    Takahashi, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Brunnemer, Eva
    Waelscher, Julia
    Tenenbaum, Svenja
    Hausmanns, Julia
    Schulze, Karen
    Seiter, Marianne
    Heussel, Claus Peter
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    [J]. RESPIRATION, 2018, 95 (05) : 301 - 309
  • [7] Pneumothorax in patients with idiopathic pulmonary fibrosis: a real-world experience
    Yamazaki, Ryo
    Nishiyama, Osamu
    Gose, Kyuya
    Saeki, Sho
    Sano, Hiroyuki
    Iwanaga, Takashi
    Tohda, Yuji
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [8] Pneumothorax in patients with idiopathic pulmonary fibrosis: a real-world experience
    Ryo Yamazaki
    Osamu Nishiyama
    Kyuya Gose
    Sho Saeki
    Hiroyuki Sano
    Takashi Iwanaga
    Yuji Tohda
    [J]. BMC Pulmonary Medicine, 21
  • [9] Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
    Levra, Stefano
    Guida, Giuseppe
    Sprio, Andrea Elio
    Crosa, Flavio
    Ghio, Paolo Carlo
    Bertolini, Francesca
    Carriero, Vitina
    Albera, Carlo
    Ricciardolo, Fabio Luigi Massimo
    [J]. BIOMEDICINES, 2022, 10 (12)
  • [10] Antifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study
    Romero Ortiz, Ana Dolores
    Maria Jimenez-Rodriguez, Beatriz
    Lopez-Ramirez, Cecilia
    Lopez-Bauza, Angela
    Perez-Morales, Maria
    Antonio Delgado-Torralbo, Jose
    Villalba Moral, Cristina
    Alcazar-Navarrete, Bernardino
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
12345